← All stocks

Candel Therapeutics, Inc.

CADL Net buying
CIK 0001841387 #2585 in the set updated 17 Sep 2026
Bought (120 mo)
$12.51M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$7.69M
$1.28M on a plan · $3.50M straight out of an exercise
Sold at will
$2.90M
30 of 43 sales
Net
+$4.82M
+$9.61M against sales at will

By person

16 insiders · 67 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Manning Paul B
Director
$10.91M (5)
+$10.91M
4,052,437
$42.37M
Tak Paul Peter
Chief Executive Officer
$230.02K (3)
$4.21M (9) scheduled
−$3.98M
113,321
$1.18M
Martell Christopher
Director
$1.05M (3)
+$1.05M
671,863
$7.03M
+437.5%
Barone Francesca
Chief Scientific Officer
$1.99K (1)
$994.66K (7) scheduled
−$992.67K
77,362
$808.93K
+5,057%
Tyagarajan Seshu
Chief Technology Officer
$25.06K (2)
$921.76K (8)
−$896.70K
76,865
$803.73K
+284.3%
Nichols William Garrett
Chief Medical Officer
$763.79K (8) scheduled
−$763.79K
52,493
$548.89K
Aguilar-Cordova Estuardo
10% owner
$486.48K (6)
−$486.48K
3,455,764
$36.13M
−28.4%
Schoch Charles
Chief Financial Officer
$311.95K (5)
−$311.95K
43,391
$453.71K
−46.6%
Canepa John J
Chief Financial Officer
$81.00K (1)
+$81.00K
10,125
$105.87K
Nguyen Diem
Director
$80.00K (1)
+$80.00K
10,000
$104.56K
PAPA JOSEPH C
Director
$73.06K (2)
+$73.06K
102,271
$1.07M
Caffo Nathan
Chief Business Officer
$48.00K (1)
+$48.00K
6,000
$62.74K
Amello Jason
Chief Financial Officer
$10.00K (2)
+$10.00K
202,009
$2.11M
Aguilar Laura K.
10% owner
3,046,940
$31.86M
+5.5%
Nabel Gary J.
Director
5,353
$55.97K
Loggia Nicoletta
Director
2,141
$22.39K

No percentages here. This company's share count has moved by a factor of 2.4 over the window, from 32,475,537 to 76,518,565 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Manning Paul B
23 Feb 2026
Director
Buy indirect
550,458
$5.45
$3.00M
Manning Paul B
16 Dec 2024
Director
Buy indirect
750,000
$6.00
$4.50M
Manning Paul B
16 Dec 2024
Director
Buy indirect
500,000
$6.00
$3.00M
Amello Jason
9 Dec 2022
Chief Financial Officer
Buy
2,468
$1.93
$4.76K
Tyagarajan Seshu
9 Dec 2022
Chief Technology Officer
Buy
10,358
$1.93
$19.99K
Tak Paul Peter
9 Dec 2022
Chief Executive Officer
Buy
12,935
$1.92
$24.84K
Martell Christopher
9 Dec 2022
Director
Buy
23,950
$1.92
$45.98K
PAPA JOSEPH C
9 Dec 2022
Director
Buy
35,018
$1.94
$67.93K
Amello Jason
8 Dec 2022
Chief Financial Officer
Buy
3,100
$1.69
$5.24K
Tyagarajan Seshu
8 Dec 2022
Chief Technology Officer
Buy
3,000
$1.69
$5.07K
Tak Paul Peter
8 Dec 2022
Chief Executive Officer
Buy
3,050
$1.70
$5.19K
Martell Christopher
8 Dec 2022
Director
Buy
3,050
$1.68
$5.12K
PAPA JOSEPH C
8 Dec 2022
Director
Buy
3,014
$1.70
$5.12K
Barone Francesca
8 Dec 2022
Chief Scientific Officer
Buy
1,238
$1.61
$1.99K
Manning Paul B
29 Jul 2021
Director
Buy
20,000
$7.30
$145.94K
Caffo Nathan
29 Jul 2021
Chief Business Officer
Buy
6,000
$8.00
$48.00K
Canepa John J
29 Jul 2021
Chief Financial Officer
Buy
10,125
$8.00
$81.00K
Tak Paul Peter
29 Jul 2021
Chief Executive Officer
Buy
25,000
$8.00
$200.00K
Nguyen Diem
29 Jul 2021
Director
Buy
10,000
$8.00
$80.00K
Martell Christopher
29 Jul 2021
Director
Buy indirect
125,000
$8.00
$1.00M
Manning Paul B
27 Jul 2021
Director
Buy
36,000
$7.36
$264.83K

What was left out

Form 4 filings counted 166
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 6
Sales at will 30
Transactions with no price 0
Shares from compensation/vesting 6,536,501
History held since 29 Jul 2021